The Leading Global Gene Therapy Conference Series

Discover Phacilitate’s Advanced Therapies series, spanning Advanced Therapies Week in North America, Advanced Therapies Europe, and the new Advanced Therapies World in the Middle East.

Bringing together the brightest minds advancing gene therapy worldwide.

Each event offers a unique regional focus but a shared goal: to accelerate progress from scientific discovery to commercial success.

Whether you’re developing a therapy, preparing for clinical trials, or scaling for market, our events provide the insight, partnerships, and visibility to move faster.

Attend a Gene Therapy Conference with Phacilitate?

At every event, you’ll find targeted content and high value networking
designed specifically for gene therapy professionals.

Advanced Therapies Week

09 - 12 February 2026 Convention Center, San Diego, USA The “Super Bow ...

Week

09 - 12 February 2026
Convention Center, San Diego, USA

The “Super Bowl” of gene and cell therapy. From early-stage discovery to clinical and commercial success, ATW gathers 2,000+ professionals for deal-making, trend-spotting, and agenda-setting. Ideal for those driving major announcements or seeking global scale.

Find Our More

Advanced Therapies Europe

07–09 September 2026 Hotel Arts, Barcelona, Spain Curated and connecte ...

Europe

07–09 September 2026
Hotel Arts, Barcelona, Spain

Curated and connected, this is Europe’s most focused event for senior biotech leaders in gene and cell therapy. Expect deep discussion on regulatory reform, manufacturing innovation, and strategic partnering, all in an intimate, invitation-based format.

Find Out More

Advanced Therapies World

10-11 November 2026 Four Seasons Hotel Riyadh, Saudi Arabia Launching ...

World

10-11 November 2026
Four Seasons Hotel Riyadh, Saudi Arabia

Launching in 2026, this event expands access across the Middle East’s fast-growing biotech market. Join a hand-selected audience of global innovators and local leaders focused on advancing gene therapies across the GCC region.

 

Find Out More

Leading Voices in Gene Therapy


See All Speakers

World Class Exhibitors

 

See All Exhibitors

What You’ll Gain From Attending

Each of our events is designed to deliver focused value depending on where you sit in the gene therapy ecosystem, from scientific discovery to commercial delivery.

  • Meet regulators, payers, and industry pioneers shaping the gene therapy landscape

  • Learn from real-world case studies, success stories and challenges

  • Join exclusive roundtables on AI, automation, and platform scalability

  • Build relationships with CDMOs, CROs, and funding partners

Have a Question?

Across all three events, gene therapy is a core focus. Sessions span clinical trials, molecular therapy innovations, CRISPR-based therapy, CAR T therapy, and the evolving regulatory landscape for gene therapies. You’ll also explore key themes such as patient access, platform scalability, and approaches to gene therapy research.

You’ll connect with global leaders across the cell and gene therapy ecosystem, including therapeutic developers, regulators, investors, CROs, CDMOs, academics, and patient advocates. Whether you’re seeking strategic partnerships or clinical collaborators, these events bring the right people together.

Expect to hear from CEOs of pioneering biotech companies, clinical leaders, regulators from the FDA and EMA, and research scientists shaping the future of gene therapy. Many are directly involved in recent gene therapy approvals or are breaking ground in next-gen platforms and clinical applications.

Yes, the show floor features companies specialising in clinical pharmacology, gene delivery technologies, manufacturing solutions, and platform innovation. You’ll find partners for every stage of your therapy’s development, from discovery through to commercialisation.

Our events offer focused tracks and roundtables built around key gene & cell therapy themes. Whether you’re looking to overcome delivery challenges, navigate regulatory hurdles, or engage with patients more effectively, you’ll find actionable insights grounded in real-world data and experience.

Absolutely. Dedicated programming supports emerging companies — from sessions on trial readiness and scale-up, to investor showcases and access to industry mentors. You’ll gain practical knowledge and meet people who understand the challenges of bringing a gene therapy to market.

Yes. Sessions include direct input from patient advocates, covering topics such as ethical trial design, informed consent, and real-world barriers to patient access. These perspectives are critical to ensuring that the therapies we develop are meaningful and accessible.

Yes. Events such as Advanced Therapies Europe offer CPD accreditation, supporting your continued growth in areas like clinical research, regulatory strategy, and innovation in gene therapy.

 

Award-winning events which focus on the science 
and commercialization of advanced therapies

Other core topics

Cell Therapy

Dive into the latest developments in gene editing, vector design, and regulatory progress shaping the future of genetic medicine. Find out more

TBC.

Learn how cell and gene therapies are transforming cancer care, from breakthrough trials to scalable, patient-ready solutions. Find out more